269 related articles for article (PubMed ID: 32553561)
1. Comparison of morphological features in lymph node metastasis between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinomas.
Takahashi D; Kojima M; Morisue R; Sugimoto M; Kobayashi S; Takahashi S; Konishi M; Gotohda N; Ikeda M; Ochiai A
Pancreatology; 2020 Jul; 20(5):936-943. PubMed ID: 32553561
[TBL] [Abstract][Full Text] [Related]
2. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases.
Nishiwada S; Sho M; Banwait JK; Yamamura K; Akahori T; Nakamura K; Baba H; Goel A
Gastroenterology; 2020 Aug; 159(2):562-574. PubMed ID: 32376411
[TBL] [Abstract][Full Text] [Related]
3. The number of positive lymph node is a better predictor of survival than the lymph node metastasis status for pancreatic neuroendocrine neoplasms: A retrospective cohort study.
Zhang X; Lu L; Shang Y; Liu P; Wei Y; Ma L; Gong P
Int J Surg; 2017 Dec; 48():142-148. PubMed ID: 29107188
[TBL] [Abstract][Full Text] [Related]
4. The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management.
Lopez-Aguiar AG; Ethun CG; Zaidi MY; Rocha FG; Poultsides GA; Dillhoff M; Fields RC; Idrees K; Cho CS; Abbott DE; Cardona K; Maithel SK
Surgery; 2019 Jul; 166(1):15-21. PubMed ID: 31072670
[TBL] [Abstract][Full Text] [Related]
5. Predictive Effect of the Total Number of Examined Lymph Nodes on N Staging and Survival in Pancreatic Neuroendocrine Neoplasms.
Zhang X; Lu L; Liu P; Cao F; Wei Y; Ma L; Gong P
Pancreas; 2018 Feb; 47(2):183-189. PubMed ID: 29329160
[TBL] [Abstract][Full Text] [Related]
6. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
Pai RK; Beck AH; Mitchem J; Linehan DC; Chang DT; Norton JA; Pai RK
Am J Surg Pathol; 2011 Feb; 35(2):228-34. PubMed ID: 21263243
[TBL] [Abstract][Full Text] [Related]
7. Clinicoradiological Factors Predicting Lymph Node Metastasis in Patients with Nonfunctioning Pancreatic Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis.
Jeong B; Heo S; Kim DW; Kim KW
Neuroendocrinology; 2024; 114(2):111-119. PubMed ID: 37703849
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic ductal adenocarcinoma and paraaortic lymph nodes metastases: The accuracy of intraoperative frozen section.
Doussot A; Bouvier A; Santucci N; Lequeu JB; Cheynel N; Ortega-Deballon P; Rat P; Facy O
Pancreatology; 2019 Jul; 19(5):710-715. PubMed ID: 31174978
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the prognostic factors and significance of lymph node status in invasive ductal carcinoma of the body or tail of the pancreas.
Fujita T; Nakagohri T; Gotohda N; Takahashi S; Konishi M; Kojima M; Kinoshita T
Pancreas; 2010 Jan; 39(1):e48-54. PubMed ID: 19910836
[TBL] [Abstract][Full Text] [Related]
10. A Comprehensive Assessment of Accurate Lymph Node Staging and Preoperative Detection in Resected Pancreatic Cancer.
Masuda T; Dann AM; Elliott IA; Baba H; Kim S; Sedarat A; Muthusamy VR; Girgis MD; Joe Hines O; Reber HA; Donahue TR
J Gastrointest Surg; 2018 Feb; 22(2):295-302. PubMed ID: 29043580
[TBL] [Abstract][Full Text] [Related]
11. Lymph Node Metastatic Patterns and Survival Predictors Based on Tumor Size in Pancreatic Ductal Adenocarcinoma.
Pu N; Chen Q; Gan W; Shen Y; Gao S; Habib JR; Yin H; Zhang J; Kinny-Köster B; Cui M; Li J; Dong Y; Nagai M; Liu L; Yu J; Wu W; Lou W
Adv Ther; 2021 Aug; 38(8):4258-4270. PubMed ID: 34176089
[TBL] [Abstract][Full Text] [Related]
12. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA
Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive histological evaluation with clinical analysis of venous invasion in pancreatic ductal adenocarcinoma: From histology to clinical implications.
Lee SJ; Sung YN; Kim SJ; Shin S; Cho H; Hruban RH; Hong SM
Pancreatology; 2020 Oct; 20(7):1486-1494. PubMed ID: 32948429
[TBL] [Abstract][Full Text] [Related]
14. Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma.
Chen HY; Zhang XY; Deng XY; Ge YL; Tang YQ; Cui H; Yang B; Pan Y; Shi D; Yu RS
AJR Am J Roentgenol; 2020 Aug; 215(2):390-397. PubMed ID: 32432906
[No Abstract] [Full Text] [Related]
15. Timing But Not Patterns of Recurrence Is Different Between Node-negative and Node-positive Resected Pancreatic Cancer.
Honselmann KC; Pergolini I; Castillo CF; Deshpande V; Ting D; Taylor MS; Bolm L; Qadan M; Wellner U; Sandini M; Bausch D; Warshaw AL; Lillemoe KD; Keck T; Ferrone CR
Ann Surg; 2020 Aug; 272(2):357-365. PubMed ID: 32675550
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a multi-parameters MRI model for predicting small lymph nodes metastases (<10 mm) in patients with resected pancreatic ductal adenocarcinoma.
Shi YJ; Liu BN; Li XT; Zhu HT; Wei YY; Zhao B; Sun SS; Sun YS; Hao CY
Abdom Radiol (NY); 2022 Sep; 47(9):3217-3228. PubMed ID: 34800159
[TBL] [Abstract][Full Text] [Related]
17. A meta-analysis of Prognostic factor of Pancreatic neuroendocrine neoplasms.
Gao Y; Gao H; Wang G; Yin L; Xu W; Peng Y; Wu J; Jiang K; Miao Y
Sci Rep; 2018 May; 8(1):7271. PubMed ID: 29739948
[TBL] [Abstract][Full Text] [Related]
18. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
[TBL] [Abstract][Full Text] [Related]
19. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients.
Parekh JR; Wang SC; Bergsland EK; Venook AP; Warren RS; Kim GE; Nakakura EK
Pancreas; 2012 Aug; 41(6):840-4. PubMed ID: 22781907
[TBL] [Abstract][Full Text] [Related]
20. Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase.
Reinert CP; Baumgartner K; Hepp T; Bitzer M; Horger M
Abdom Radiol (NY); 2020 Mar; 45(3):750-758. PubMed ID: 31953587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]